{
  "url": "https://openlegislation.uk/medicines-applications-for-grant-of-product-licencesproducts-for-human-use-regulations-1993/schedule-2/paragraph-5",
  "json_url": "https://openlegislation.uk/medicines-applications-for-grant-of-product-licencesproducts-for-human-use-regulations-1993/schedule-2/paragraph-5.json",
  "legislation": "uksi/1993/2538",
  "legislation_title": "The Medicines (Applications for Grant of Product Licences—Products for Human Use) Regulations 1993",
  "legislation_url": "https://openlegislation.uk/medicines-applications-for-grant-of-product-licencesproducts-for-human-use-regulations-1993",
  "path": "schedule/2/paragraph/5",
  "kind": "paragraph",
  "number": "5",
  "heading": null,
  "text": "Subject to compliance with paragraphs 19(a) and 22 of Schedule 1, the applicant shall not be required, under paragraph 8 of that Schedule, to provide, in relation to particular therapeutic indications, the results of any tests or trials where, in respect of those indications, he can show that he is unable to provide comprehensive information on the quality, efficacy and safety under normal conditions of use because:\n(a) the indications for which the product is intended are encountered so rarely that the applicant cannot reasonably be expected to provide comprehensive evidence;\n(b) in the present state of scientific knowledge comprehensive information cannot be provided; or\n(c) it would be contrary to generally accepted principles of medical ethics to collect such information;\nand where the applicant wishes the licensing authority to consider granting the licence on the basis that he would be required to carry out a programme of studies for the purposes of reassessing the benefit/risk profile, that the product would be supplied on medical prescription only (and subject to any other relevant restrictions) and that he would be required to provide relevant information in the package leaflet and medical information.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [
    {
      "type": "words substituted",
      "affecting": "uksi/2002/236",
      "affecting_title": "The Medicines (Codification Amendments Etc.) Regulations 2002"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/1993/2538/schedule/2/paragraph/5",
    "retrieved_at": "2026-10-29T13:49:32.233655+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}